LGT Fund Management Co Ltd. Raises Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

LGT Fund Management Co Ltd. increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 23.0% in the 4th quarter, Holdings Channel.com reports. The fund owned 1,230 shares of the medical equipment provider’s stock after acquiring an additional 230 shares during the quarter. LGT Fund Management Co Ltd.’s holdings in Intuitive Surgical were worth $642,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Bennett Selby Investments LP increased its holdings in Intuitive Surgical by 3.9% in the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock worth $234,000 after acquiring an additional 17 shares in the last quarter. Onefund LLC increased its holdings in Intuitive Surgical by 1.9% in the 4th quarter. Onefund LLC now owns 947 shares of the medical equipment provider’s stock worth $494,000 after acquiring an additional 18 shares in the last quarter. LVW Advisors LLC increased its holdings in Intuitive Surgical by 1.3% in the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock worth $756,000 after acquiring an additional 19 shares in the last quarter. Wesbanco Bank Inc. grew its holdings in shares of Intuitive Surgical by 1.6% during the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock worth $635,000 after buying an additional 19 shares in the last quarter. Finally, FSM Wealth Advisors LLC grew its holdings in shares of Intuitive Surgical by 3.7% during the fourth quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider’s stock worth $275,000 after buying an additional 19 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the stock. Raymond James upped their target price on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Royal Bank of Canada upped their target price on shares of Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and upped their target price for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. Evercore ISI upped their target price on shares of Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Finally, JPMorgan Chase & Co. upped their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. One research analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average price target of $613.10.

Insider Buying and Selling at Intuitive Surgical

In other news, CFO Jamie Samath sold 269 shares of the stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $590.00, for a total transaction of $158,710.00. Following the sale, the chief financial officer now owns 3,282 shares of the company’s stock, valued at approximately $1,936,380. This represents a 7.58 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Myriam Curet sold 408 shares of the stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total transaction of $240,618.00. Following the sale, the executive vice president now directly owns 353 shares in the company, valued at $208,181.75. This represents a 53.61 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 12,598 shares of company stock valued at $7,223,467 over the last 90 days. 0.90% of the stock is owned by insiders.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $566.98 on Tuesday. The firm’s 50-day moving average is $570.66 and its two-hundred day moving average is $530.08. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The stock has a market capitalization of $201.95 billion, a P/E ratio of 88.45, a PEG ratio of 5.85 and a beta of 1.39.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.